News

ArchiMed’s purchase will accelerate ActiGraph’s expansion within the complex, highly regulated global drug development industry. Private equity healthcare specialist, ArchiMed has acquired ActiGraph, a pioneering developer of wearable, remote monitoring technology for academic studies and drug trials. ActiGraph’s mobility and sleep tracking hardware, software and analysis solutions are the most widely used research-grade monitoring systems…

NorthEdge drives 3x return on cross-border DHG sale – NorthEdge Capital has completed the sale of Direct Healthcare Group (DHG) in a secondary buyout by European healthcare specialist investor ArchiMed. The deal sees NorthEdge secure a 3x return on its initial investment, with an IRR of 39 per cent. NorthEdge led a management buyout of…

ArchiMed, European private equity healthcare specialist, announces successful growth of its portfolio company Micromed into Neurodiagnostics – on both sides of the Atlantic. Archimed expands neurodiagnostic business in Europe and the US Portfolio Company, Micromed, a European-based neurodiagnostic system manufacturer has moved to direct sales in the United States and its wholly owned subsidiary, US based Moberg…

Specialist healthcare investor ArchiMed has acquired a majority stake in Netherlands-based Soest Medical Group (SMG) which produces adhesives used during surgery. SMG has two brands: seller of reusable adhesives Eurotape and disposable adhesives provider Somed. Its revenues are growing at a rate of around 10 per cent annually, according to ArchiMed. With ArchiMed’s backing, SMG…

France-based ArchiMed, a healthcare-focused private equity firm, have hired Benoît Adelus and André-Michel Ballester as partners. Adelus was the chairman and CEO of Sebia while Ballester is currently chairman of ArchiMed portfolio company Citieffe. PRESS RELEASE February 12, 2018 – Benoît Adelus and André-Michel Ballester are joining the senior management of European private equity healthcare…